Antimetabolite antineoplastic agents interfere. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Tumor Cells, Cultured Cell Line, Tumor Cell Line HL-60 Cells Cells, Cultured HT29 Cells

Organisms6

Narcissus Streptomyces Mice, Nude Aster Plant Olacaceae Mice, Inbred BALB C

Diseases14

Leukemia P388 Neoplasms Leukemia L1210 Sarcoma 180 Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Leukemia Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms Phlebitis Carcinoma, Ehrlich Tumor Lymphoma

Chemicals and Drugs81

Antineoplastic Agents Antimetabolites Antimetabolites, Antineoplastic 6-Mercaptopurine Antineoplastic Agents, Phytogenic Fluorouracil Thioguanine Amaryllidaceae Alkaloids Methotrexate Vidarabine Phosphate Ellipticines 6-Aminonicotinamide Bibenzyls Tetrahydrouridine Doxorubicin Antibiotics, Antineoplastic Pantothenic Acid Norleucine Thiadiazines Bryostatins Deoxycytidine Antineoplastic Agents, Alkylating Mitomycin Ancitabine Cytarabine Floxuridine Gallium Depsipeptides Cisplatin Paclitaxel Thymidylate Synthase Phosphonoacetic Acid Aminoacridines Epothilones Azathioprine Guanine Lactones Daunorubicin Bleomycin Etoposide Prodrugs Macrolides Camptothecin Stilbenes Enzyme Inhibitors Vincristine Isoquinolines Cyclophosphamide Caspases Taxoids DNA Phospholipid Ethers RNA, Messenger Reactive Oxygen Species Sulindac Amsacrine Vanadium Compounds Hazardous Substances Thiosemicarbazones 2-Propanol Carmustine Topoisomerase II Inhibitors Farnesyltranstransferase Drugs, Investigational Isocoumarins Nitrogen Mustard Compounds Dioxoles Suramin Alkaloids Plant Extracts Topoisomerase I Inhibitors Azacitidine DNA Adducts DNA Topoisomerases, Type II Anti-Inflammatory Agents, Non-Steroidal Nitrosourea Compounds Pyrones Pyrazines Hydrazones Sulfonamides DNA, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment24

Surgical Sponges Drug Screening Assays, Antitumor Trabeculectomy Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Drug Evaluation Xenograft Model Antitumor Assays Neoplasms, Experimental Drug Administration Schedule Neoplasm Transplantation Clinical Trials as Topic Gloves, Protective Treatment Outcome Protective Devices Equipment and Supplies, Hospital Protective Clothing Inhibitory Concentration 50 Drug Compounding Antineoplastic Protocols Tumor Stem Cell Assay Comet Assay Lethal Dose 50 Mutagenicity Tests Blotting, Western

Phenomena and Processes24

Drug Synergism Apoptosis Cell Survival Cell Division Molecular Structure Dose-Response Relationship, Drug Drug Resistance, Neoplasm Drug Resistance Cell Cycle Cell Proliferation Biotransformation Drug Interactions DNA Damage Stereoisomerism Time Factors Kinetics Structure-Activity Relationship Dental Physiological Processes Inhibitory Concentration 50 Drug Resistance, Multiple DNA Adducts Lethal Dose 50 Gene Expression Regulation, Neoplastic Metabolic Detoxication, Drug

Disciplines and Occupations1

Oncology Nursing

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care16

Clinical Trials as Topic Occupational Exposure Treatment Outcome Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Antineoplastic Protocols Pharmacies Oncology Service, Hospital Nurses Hospitals Pharmacists

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Named Groups Health Care

Antineoplastic Agents Antimetabolites Antimetabolites, Antineoplastic 6-Mercaptopurine Surgical Sponges Antineoplastic Agents, Phytogenic Fluorouracil Leukemia P388 Thioguanine Amaryllidaceae Alkaloids Methotrexate Vidarabine Phosphate Narcissus Ellipticines 6-Aminonicotinamide Bibenzyls Tetrahydrouridine Doxorubicin Drug Screening Assays, Antitumor Neoplasms Leukemia L1210 Tumor Cells, Cultured Trabeculectomy Antibiotics, Antineoplastic Drug Synergism Pantothenic Acid Norleucine Thiadiazines Bryostatins Deoxycytidine Antineoplastic Agents, Alkylating Apoptosis Cell Survival Mitomycin Ancitabine Cytarabine Floxuridine Gallium Cell Division Depsipeptides Cisplatin Antineoplastic Combined Chemotherapy Protocols Paclitaxel Thymidylate Synthase Phosphonoacetic Acid Aminoacridines Epothilones Cell Line, Tumor Azathioprine Sarcoma 180 Molecular Structure Guanine Lactones Daunorubicin Bleomycin Streptomyces Dose-Response Relationship, Drug Cell Line Etoposide Drug Resistance, Neoplasm Prodrugs Drug Evaluation, Preclinical Drug Evaluation Xenograft Model Antitumor Assays Drug Resistance Macrolides Neoplasms, Experimental Camptothecin Stilbenes Cell Cycle Mice, Nude HL-60 Cells Enzyme Inhibitors Cell Proliferation Lung Neoplasms Drug Administration Schedule Vincristine Isoquinolines Neoplasm Transplantation Biotransformation Drug Interactions Breast Neoplasms DNA Damage Cyclophosphamide Stereoisomerism Time Factors Clinical Trials as Topic Leukemia Kinetics Ovarian Neoplasms Colonic Neoplasms Caspases Taxoids Prostatic Neoplasms Structure-Activity Relationship DNA Phospholipid Ethers RNA, Messenger Reactive Oxygen Species Cells, Cultured

No FAQ available that match "antimetabolite antineoplastic agents interfere"